Skip to main content
Premium Trial:

Request an Annual Quote

GNS, CHDI Partner on Huntington's Disease Model

NEW YORK (GenomeWeb News) – GNS Healthcare and the CHDI Foundation jointly announced today that they will collaborate on the development of a data-driven computer model of Huntington's disease intended to drive personalized medicine research.

The alliance will make use of GNS' Reverse Engineering and Forward Simulation platform to develop network models from genomic, expression, and cell signaling data. The partners expect that results from millions of in silico simulations of the REFS models will provide insight into the mechanisms of Huntington's disease and lead to more effective treatments.

"This collaboration with CHDI is representative of our focus on using big data analytics to reveal new insights into a disease and provide tools for scientists that will help transform the tremendous amount of information coming from new technologies such as next-generation sequencing into predictive computer models of disease progression and drug response," GNS Executive VP and Co-founder Iya Khalil.

Once the REFS models are completed they will be transferred to CHDI and its affiliated researchers.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.